Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery
2007-01-01 Lorusso, D; Ferrandina, G.; Pagano, L.; Gagliardi, M. L.; Scambia, G.
Impact of Morcellation of Occult Malignancies at the Time of Vaginal Hysterectomy
2017-01-01 Bogani, G; Signorelli, M; Chiappa, V; Lorusso, D; Raspagliesi, F.
Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors A MITO-9 Retrospective Study
2011-01-01 Mangili, Giorgia; Sigismondi, Cristina; Gadducci, Angiolo; Cormio, Gennaro; Scollo, Paolo; Tateo, Saverio; Ferrandina, Gabriella; Greggi, Stefano; Candiani, Massimo; Lorusso, D
Investigational agents against platinum-resistant ovarian cancer
2007-01-01 Lorusso, D; Ferrandina, Gabriella; Fanfani, Francesco; Gagliardi Maria, Lucia; Scambia, Giovanni
Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study
2019-01-01 Fucà, G; Hindi, N; Ray-Coquard, I; Colia, V; Dei Tos, Ap; Martin-Broto, J; Brahmi, M; Collini, P; Lorusso, D; Raspagliesi, F; Pantaleo, Ma; Vincenzi, B; Fumagalli, E; Gronchi, A; Casali, Pg; Sanfilippo, R.
Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer
2018-01-01 Bogani, G; Ditto, A; Leone Roberti Maggiore, U; Scaffa, C; Mosca, L; Chiappa, V; Martinelli, F; Lorusso, D; Raspagliesi, F
Surveillance Policy for Stage IA Malignant Ovarian Germ Cell Tumors in Children and Young Adults
2014-01-01 Mangili, G; Sigismondi, C; Lorusso, D; Pignata, S
Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
2018-01-01 Bogani, G; Rossetti, D; Ditto, A; Martinelli, F; Chiappa, V; Mosca, L; Leone Roberti Maggiore, U; Ferla, S; Lorusso, D; Raspagliesi, F
Trophoblastic Disease Review for Diagnosis and Management A Joint Report From the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup
2014-01-01 Mangili, G; Lorusso, D; Brown, J; Pfisterer, J; Massuger, L; Vaughan, M; Ngan, Hys; Golfier, F; Sekharan, Pk; Charry, Rc; Poveda, A; Kim, Jw; Xiang, Y; Berkowtiz, R; Seckl, Mj
Safety and effectiveness of Human Papillomavirus (HPV) vaccination: NCI of Milan position statement
2017-01-01 Bogani, G; Lorusso, D; Raspagliesi, F.
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study
2017-01-01 Pignata, S; Scambia, G; Bologna, A; Signoriello, S; Vergote, Ib; Wagner, U; Lorusso, D; Murgia, V; Sorio, R; Ferrandina, G; Sacco, C; Cormio, G; Breda, E; Cinieri, S; Natale D, ; Mangili, G; Pisano, C; Cecere, Sc; Di Napoli, M; Salutari, V; Raspagliesi, F; Arenare, L; Bergamini, A; Bryce, J; Daniele, G; Piccirillo, Mc; Gallo, C; Perrone, F.
Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer
2018-01-01 Ditto, A; Bogani, G; Leone Roberti Maggiore, U; Martinelli, F; Chiappa, V; Lopez, C; Perotto, S; Lorusso, D; Raspagliesi, F.
Is Postoperative Computed Tomography Evaluation a Prognostic Indicator in Patients with Optimally Debulked Advanced Ovarian Cancer?
2014-01-01 Lorusso, D; Sarno, I; Di Donato, V; Palazzo, A; Torrisi, E; Pala, L; Marchiano, A; Raspagliesi, F
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study
2017-01-01 Mangili, G; Sigismondi, C; Lorusso, D; Cormio, G; Candiani, M; Scarfone, G; Mascilini, F; Gadducci, A; Mosconi, Am; Scollo, P; Cassani, C; Pignata, S; Ferrandina, G
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
2020-01-01 Banerjee, S; Gonzalez-Martin, A; Harter, P; Lorusso, D; Moore, Kn; Oaknin, A; Ray-Coquard, I
Phase II Trial on Cisplatin-Adriamycin-Paclitaxel Combination as Neoadjuvant Chemotherapy for Locally Advanced Cervical Adenocarcinoma
2014-01-01 Lorusso, D; Ramondino, S; Mancini, M; Zanaboni, F; Ditto, A; Raspagliesi, F
Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green
2017-01-01 Martinelli, F; Ditto, A; Bogani, G; Signorelli, M; Chiappa, V; Lorusso, D; Haeusler, E; Raspagliesi, F
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study
2020-01-01 Lorusso, D.; Marchetti, C.; Conte, C.; Giudice, E.; Bolomini, G.; Vertechy, L.; Ceni, V.; Ditto, A.; Ferrandina, G.; Raspagliesi, F.; Scambia, G.; Fagotti, A.
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
2017-01-01 Coleman, Rl; Oza, Am; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Colombo, N; Weberpals, Ji; Clamp, A; Scambia, G; Leary, A; Holloway, Rw; Gancedo, Ma; Fong, Pc; Goh, Jc; O'Malley, Dm; Armstrong, Dk; Garcia-Donas, J; Swisher, Em; Floquet, A; Konecny, Ge; Mcneish, Ia; Scott, Cl; Cameron, T; Maloney, L; Isaacson, J; Goble, S; Grace, C; Harding TC, ; Raponi, M; Sun, J; Lin, Kk; Giordano, H; Ledermann, Ja; Ariel3, Investigators.
What do you think about these data regarding trabectedin plus PLD in fully sensitive patients?
2013-01-01 Lorusso, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery | 1-gen-2007 | Lorusso, D; Ferrandina, G.; Pagano, L.; Gagliardi, M. L.; Scambia, G. | |
| Impact of Morcellation of Occult Malignancies at the Time of Vaginal Hysterectomy | 1-gen-2017 | Bogani, G; Signorelli, M; Chiappa, V; Lorusso, D; Raspagliesi, F. | |
| Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors A MITO-9 Retrospective Study | 1-gen-2011 | Mangili, Giorgia; Sigismondi, Cristina; Gadducci, Angiolo; Cormio, Gennaro; Scollo, Paolo; Tateo, Saverio; Ferrandina, Gabriella; Greggi, Stefano; Candiani, Massimo; Lorusso, D | |
| Investigational agents against platinum-resistant ovarian cancer | 1-gen-2007 | Lorusso, D; Ferrandina, Gabriella; Fanfani, Francesco; Gagliardi Maria, Lucia; Scambia, Giovanni | |
| Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study | 1-gen-2019 | Fucà, G; Hindi, N; Ray-Coquard, I; Colia, V; Dei Tos, Ap; Martin-Broto, J; Brahmi, M; Collini, P; Lorusso, D; Raspagliesi, F; Pantaleo, Ma; Vincenzi, B; Fumagalli, E; Gronchi, A; Casali, Pg; Sanfilippo, R. | |
| Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer | 1-gen-2018 | Bogani, G; Ditto, A; Leone Roberti Maggiore, U; Scaffa, C; Mosca, L; Chiappa, V; Martinelli, F; Lorusso, D; Raspagliesi, F | |
| Surveillance Policy for Stage IA Malignant Ovarian Germ Cell Tumors in Children and Young Adults | 1-gen-2014 | Mangili, G; Sigismondi, C; Lorusso, D; Pignata, S | |
| Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer | 1-gen-2018 | Bogani, G; Rossetti, D; Ditto, A; Martinelli, F; Chiappa, V; Mosca, L; Leone Roberti Maggiore, U; Ferla, S; Lorusso, D; Raspagliesi, F | |
| Trophoblastic Disease Review for Diagnosis and Management A Joint Report From the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup | 1-gen-2014 | Mangili, G; Lorusso, D; Brown, J; Pfisterer, J; Massuger, L; Vaughan, M; Ngan, Hys; Golfier, F; Sekharan, Pk; Charry, Rc; Poveda, A; Kim, Jw; Xiang, Y; Berkowtiz, R; Seckl, Mj | |
| Safety and effectiveness of Human Papillomavirus (HPV) vaccination: NCI of Milan position statement | 1-gen-2017 | Bogani, G; Lorusso, D; Raspagliesi, F. | |
| Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study | 1-gen-2017 | Pignata, S; Scambia, G; Bologna, A; Signoriello, S; Vergote, Ib; Wagner, U; Lorusso, D; Murgia, V; Sorio, R; Ferrandina, G; Sacco, C; Cormio, G; Breda, E; Cinieri, S; Natale D, ; Mangili, G; Pisano, C; Cecere, Sc; Di Napoli, M; Salutari, V; Raspagliesi, F; Arenare, L; Bergamini, A; Bryce, J; Daniele, G; Piccirillo, Mc; Gallo, C; Perrone, F. | |
| Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer | 1-gen-2018 | Ditto, A; Bogani, G; Leone Roberti Maggiore, U; Martinelli, F; Chiappa, V; Lopez, C; Perotto, S; Lorusso, D; Raspagliesi, F. | |
| Is Postoperative Computed Tomography Evaluation a Prognostic Indicator in Patients with Optimally Debulked Advanced Ovarian Cancer? | 1-gen-2014 | Lorusso, D; Sarno, I; Di Donato, V; Palazzo, A; Torrisi, E; Pala, L; Marchiano, A; Raspagliesi, F | |
| The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study | 1-gen-2017 | Mangili, G; Sigismondi, C; Lorusso, D; Cormio, G; Candiani, M; Scarfone, G; Mascilini, F; Gadducci, A; Mosconi, Am; Scollo, P; Cassani, C; Pignata, S; Ferrandina, G | |
| First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion | 1-gen-2020 | Banerjee, S; Gonzalez-Martin, A; Harter, P; Lorusso, D; Moore, Kn; Oaknin, A; Ray-Coquard, I | |
| Phase II Trial on Cisplatin-Adriamycin-Paclitaxel Combination as Neoadjuvant Chemotherapy for Locally Advanced Cervical Adenocarcinoma | 1-gen-2014 | Lorusso, D; Ramondino, S; Mancini, M; Zanaboni, F; Ditto, A; Raspagliesi, F | |
| Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green | 1-gen-2017 | Martinelli, F; Ditto, A; Bogani, G; Signorelli, M; Chiappa, V; Lorusso, D; Haeusler, E; Raspagliesi, F | |
| Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study | 1-gen-2020 | Lorusso, D.; Marchetti, C.; Conte, C.; Giudice, E.; Bolomini, G.; Vertechy, L.; Ceni, V.; Ditto, A.; Ferrandina, G.; Raspagliesi, F.; Scambia, G.; Fagotti, A. | |
| Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial | 1-gen-2017 | Coleman, Rl; Oza, Am; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Colombo, N; Weberpals, Ji; Clamp, A; Scambia, G; Leary, A; Holloway, Rw; Gancedo, Ma; Fong, Pc; Goh, Jc; O'Malley, Dm; Armstrong, Dk; Garcia-Donas, J; Swisher, Em; Floquet, A; Konecny, Ge; Mcneish, Ia; Scott, Cl; Cameron, T; Maloney, L; Isaacson, J; Goble, S; Grace, C; Harding TC, ; Raponi, M; Sun, J; Lin, Kk; Giordano, H; Ledermann, Ja; Ariel3, Investigators. | |
| What do you think about these data regarding trabectedin plus PLD in fully sensitive patients? | 1-gen-2013 | Lorusso, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26879
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269083
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS227
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE182
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19160
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24626
- reserved1362
- open891